| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656184 | 06360001 | CHAMPIX 0,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CHAMPIX 0,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 0,5 mg | 6 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06360001/06360001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06360001/06360001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2006-10-25 | 1 | 1 | 1 | 2006-10-25 | 2006-10-25 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 697866 | 06360005 | CHAMPIX 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CHAMPIX 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 1 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06360005/06360005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06360005/06360005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2006-10-25 | 1 | 1 | 1 | 2006-10-25 | 2006-10-25 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 697864 | 06360012 | CHAMPIX 0,5, 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CHAMPIX 0,5, 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, (0,5 mg) 11 comp + (1 mg) 14 comp + (1 mg) 28 comp | 0,5 mg + 1 mg | 5 | 53 | 10 | (0,5 mg) 11 comp + (1 mg) 14 comp + (1 mg) 28 comp | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06360012/06360012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06360012/06360012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2008-05-14 | 1 | 1 | 1 | 2008-05-14 | 2008-05-14 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 656939 | 06363004 | SPRYCEL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363004/06363004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363004/06363004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2009-12-23 | 1 | 2011-10-18 | 656418 | View Edit Delete | |||||||||||
| 652769 | 06363005 | SPRYCEL 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363005/06363005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363005/06363005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2012-01-17 | 1 | 2013-01-03 | 656419 | View Edit Delete | |||||||||||
| 652751 | 06363006 | SPRYCEL 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 70 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363006/06363006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363006/06363006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2012-01-17 | 1 | 2013-01-03 | 656420 | View Edit Delete | |||||||||||
| 658667 | 06364002 | ADROVANCE 70 MG/2.800 UI COMPRIMIDOS | ADROVANCE 70 MG/2.800 UI COMPRIMIDOS , 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364002/06364002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364002/06364002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ORGANON SALUD S.L. | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 660438 | 06364007 | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS , 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007/06364007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007/06364007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ORGANON SALUD S.L. | 2008-02-05 | 1 | 1 | 1 | 2008-02-05 | 2008-02-05 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 765350 | 06364007IP | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007IP/06364007IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007IP/06364007IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ELAM PHARMA LABS S.L. | 2024-07-12 | 1 | 1 | 1 | 2024-07-13 | 2024-07-12 | 1 | 2025-04-23 | View Edit Delete | ||||||||||||
| 767547 | 06364007IP1 | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007IP1/06364007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007IP1/06364007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | MELYFARMA S.L. | 2025-05-06 | 1 | 1 | 1 | 2025-05-07 | 2025-05-06 | 1 | 2025-08-13 | View Edit Delete | ||||||||||||
| 658306 | 06365001 | ELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 2 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/06365001/06365001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06365001/06365001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2007-02-08 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 663163 | 06366006 | TANDEMACT 30 mg/4 mg COMPRIMIDOS | TANDEMACT 30 mg/4 mg COMPRIMIDOS, 28 comprimidos | 4 mg/30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06366006/06366006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06366006/06366006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2009-09-29 | 1 | 1 | 1 | 2009-09-29 | 2009-09-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 663162 | 06366018 | TANDEMACT 30 mg/2 mg COMPRIMIDOS | TANDEMACT 30 mg/2 mg COMPRIMIDOS, 28 comprimidos | 2 mg/30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06366018/06366018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06366018/06366018_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2009-09-29 | 1 | 1 | 1 | 2009-09-29 | 2009-09-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 661639 | 06367002 | DIACOMIT 250 mg CAPSULAS DURAS | DIACOMIT 250 mg CAPSULAS DURAS, 60 cápsulas | 250 mg | 6 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367002/06367002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367002/06367002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2015-11-11 | View Edit Delete | ||||||||||||
| 661641 | 06367005 | DIACOMIT 500 mg CAPSULAS DURAS | DIACOMIT 500 mg CAPSULAS DURAS, 60 cápsulas | 500 mg | 6 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367005/06367005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367005/06367005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2019-10-28 | View Edit Delete | ||||||||||||
| 661640 | 06367008 | DIACOMIT 250 mg POLVO PARA SUSPENSION ORAL | DIACOMIT 250 mg POLVO PARA SUSPENSION ORAL, 60 sobres | 250 mg | 35 | 60 | 64 | 60 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367008/06367008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367008/06367008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2015-11-11 | View Edit Delete | ||||||||||||
| 661642 | 06367011 | DIACOMIT 500 mg POLVO PARA SUSPENSION ORAL | DIACOMIT 500 mg POLVO PARA SUSPENSION ORAL, 60 sobres | 500 mg | 35 | 60 | 64 | 60 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367011/06367011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367011/06367011_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2019-10-28 | View Edit Delete | ||||||||||||
| 654849 | 06370011 | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370011/06370011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370011/06370011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658408, 663429 | View Edit Delete | |||||||||||
| 654850 | 06370019 | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370019/06370019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370019/06370019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658409, 663430 | View Edit Delete | |||||||||||
| 654857 | 06371011 | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06371011/06371011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06371011/06371011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2007-04-02 | 1 | 1 | 1 | 2007-04-02 | 2014-03-17 | 0 | 2011-02-24 | 671928 | View Edit Delete |
Page 27 of 1035, showing 20 records out of 20697 total, starting on record 521, ending on 540